Synopsis: Indian pharmaceutical shares slumped sharply as investors reacted to the U.S. announcement of a 100% tariff on branded and patented drugs. The Nifty Pharma Index fell 2.1%, its steepest decline in weeks, though experts believe the impact on Indian exporters may be less severe since generics are exempt. Indian pharmaceutical stocks faced heavy selling […]
